Application: competition ligand- receptor binding to screen new inhibitors, antagonists and antibodies in 384 tests.
DLL4 and NOTCH3 were identified as key drivers of diabetic vasculopathy in human blood vessels. (Wimmer RA,et al. Human blood vessel organoids as a model of diabetic vasculopathy. Nature. 2019 Jan;565(7740):505-510.)
